REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
30/03/2021 16:35
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210330:nBw71jzkya&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
2021-03-26 IRISH TOP 8.3 REPORT WILLIS AON AMENDMENT
FORM 8.3 Amendment to purchase and sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note ORD
2)
Date of dealing 26 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,740,639 1.35% 190,549 0.15%
(2) Derivatives (other than options):
102,935 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,849,674 1.43% 203,715 0.16%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 225.3900 USD
Purchase 4 226.3325 USD
Purchase 4 224.7100 USD
Purchase 9 224.7861 USD
Purchase 10 225.9465 USD
Purchase 27 226.4700 USD
Purchase 84 223.9900 USD
Purchase 143 226.3372 USD
Purchase 222 226.0497 USD
Purchase 243 224.4856 USD
Purchase 267 226.3677 USD
Purchase 313 226.8889 USD
Purchase 362 226.6075 USD
Purchase 550 226.4056 USD
Purchase 606 227.0831 USD
Purchase 881 225.8929 USD
Purchase 1,541 228.0120 USD
Purchase 1,780 227.2607 USD
Purchase 2,562 224.7107 USD
Purchase 3,865 226.1068 USD
Purchase 6,200 225.9812 USD
Purchase 6,694 226.2313 USD
Purchase 12,715 229.0735 USD
Purchase 14,267 229.3600 USD
Purchase 15,052 226.0988 USD
Purchase 21,893 226.0628 USD
Purchase 26,094 228.3599 USD
Sale 2 226.2750 USD
Sale 6 225.8275 USD
Sale 18 226.7500 USD
Sale 36 226.8200 USD
Sale 41 229.2631 USD
Sale 46 226.6500 USD
Sale 48 226.3668 USD
Sale 48 226.6537 USD
Sale 54 227.1205 USD
Sale 60 227.7305 USD
Sale 62 228.3396 USD
Sale 84 227.4903 USD
Sale 93 226.5200 USD
Sale 96 227.1696 USD
Sale 100 226.6200 USD
Sale 100 226.4100 USD
Sale 114 226.8002 USD
Sale 114 227.5276 USD
Sale 128 225.7139 USD
Sale 140 226.0407 USD
Sale 150 227.4588 USD
Sale 197 226.4283 USD
Sale 200 225.9300 USD
Sale 267 226.3677 USD
Sale 282 226.7562 USD
Sale 363 226.4381 USD
Sale 518 225.5108 USD
Sale 608 226.0789 USD
Sale 663 227.0916 USD
Sale 743 225.7970 USD
Sale 890 227.2607 USD
Sale 1,214 224.2330 USD
Sale 1,600 225.7643 USD
Sale 1,675 224.9881 USD
Sale 2,345 225.8638 USD
Sale 3,144 226.7900 USD
Sale 6,945 226.2613 USD
Sale 7,834 225.9458 USD
Sale 10,000 226.5027 USD
Sale 11,597 229.3191 USD
Sale 13,268 229.3600 USD
Sale 13,282 226.0112 USD
Sale 14,481 226.0094 USD
Sale 22,002 228.8467 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure 30 March 2021
Contact name Large Holdings Regulatory Operations
Telephone number 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivativepositions (except for
CFDs), full details shouldbe given. Full details of any existing agreements to
purchase or to sell must also be given on this form.
2. For all pricesand other monetaryamounts, the currencymust be stated.
For full details of disclosure requirements, see Rules 8 and 38.5 of the
Rules. If in doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210330005808/en/
(https://www.businesswire.com/news/home/20210330005808/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement